What other stocks do shareholders of AltheaDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AltheaDx investors own include Broadcom (AVGO) , Imunon (CLSN) , NIO (NIO) , Electrameccanica Vehicles (SOLO) , Workhorse Group (WKHS) , Walmart (WMT) , Achillion Pharmaceuticals (ACHN) , Acer Therapeutics (ACER) , American Airlines Group (AAL) .

When did AltheaDx IPO?

AltheaDx (IDGX) raised $60 million in an IPO on Wednesday, February 11th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

NASDAQ:IDGX

AltheaDx (IDGX) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free IDGX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get AltheaDx alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About AltheaDx

AltheaDx, Inc. is a United States-based commercial-stage molecular diagnostics company. The Company is specialized in the field of pharmacogenetics. The Company focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. The Company’s IDgenetix pharmacogenetic testing portfolio addresses various clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. The IDgenetix testing process consists of three steps: drug metabolism genotyping, drug response genotyping and algorithm screening. Its algorithm-based bioinformatic platform and pharmacogenetics product testing portfolio are intended to serve as a tool to assist healthcare providers in identifying optimal drugs for their patients, as well as dosing guidelines based on a patient’s genetic make-up, prescription regimen and other key factors.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

IDGX Stock News Headlines

January 11, 2023 | benzinga.com

Global Molecular Diagnostics Market Research Report 2022 to 2028: Infectious Diseases are Dominating the Industry

September 24, 2022 | bizjournals.com

Houston Pharmaceuticals News

See More Headlines

Receive IDGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AltheaDx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:IDGX
CUSIP: N/A
CIK: N/A
Web: www.altheadx.com
Phone: +1-858-8820123
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Francois Ferre Ph.D.
Chairman of the Board
Jorge A. Garces Ph.D. (Age 46)
President, Chief Executive Officer
Andrew Jackson
Chief Financial Officer
Joel Centeno
Senior Vice President, Regulatory Affairs and Quality Assurance
Andrew Lukowiak Ph.D.
Senior Vice President - Operations

IDGX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of AltheaDx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AltheaDx investors own include Broadcom (AVGO), Imunon (CLSN), NIO (NIO), Electrameccanica Vehicles (SOLO), Workhorse Group (WKHS), Walmart (WMT), Achillion Pharmaceuticals (ACHN), Acer Therapeutics (ACER), American Airlines Group (AAL).
When did AltheaDx IPO?: AltheaDx (IDGX) raised $60 million in an IPO on Wednesday, February 11th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

This page (NASDAQ:IDGX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AltheaDx (IDGX) Stock Price, News & Analysis

About AltheaDx

IDGX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

IDGX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info